Dr. Viktor Lemgart, PhDSenior Scientist, In Vivo Immune Cell Reprogramming at SanofiSpeaker
Profile
With an engineering background from the Technical University of Denmark, Viktor is focused on designing and testing novel mRNA-LNPs that can be used in Sanofi’s LNP-mRNA platform to target various immune cells directly in vivo.
Agenda Sessions
In vivo Reprogramming of Immune Cells Using Targeted LNPs
, 11:15amView Session